FDA Drug Application (021964) for RELISTOR by SALIX PHARMS

Back to FDA Applications sponsored by SALIX PHARMS

Application Number021964
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage12MG/0.6ML (12MG/0.6ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRELISTOR
Active IngredientMETHYLNALTREXONE BROMIDE



Back to FDA Applications sponsored by SALIX PHARMS